This is a 2-part study where all participants will receive bepirovirsen. The study will measure how much bepirovirsen from a single dose gets into the blood, and how long it stays in the blood. The purpose of the study is to understand if blood levels of bepirovirsen are different in adults with kidney disease compared to healthy adults who do not have kidney disease.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-10; most recent amendment 2026-05-20.
Status change: Recruiting → Active, Not Recruiting2026-05-20
Status change: Not Yet Recruiting → Recruiting2025-10-14